ArticleJournal of ovarian research2023

A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.

Xuyao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.